Invokana Amputation Lawsuit

Recently, two large clinical trials have found that the use of Invokana doubles the risk of lower limb amputations compared with those on an inactive treatment.

May 2016: FDA Investigates Risk of Amputations with Invokana

In May 2016, the U.S. Food and Drug Administration (FDA) issued a public warning following the findings from an ongoing clinical trial stating that patients treated with Invokana have an increased risk of leg and foot amputations, mostly affecting the toes.

The FDA suggested that patients continue their diabetes treatment and do not stop taking Invokana without first discussing it with their doctor. As for the health care professionals, the FDA suggested to closely monitor their patients for the signs and symptoms of the lower limb amputations.

May 2017: FDA Issues Invokana Amputation Black Box Warning

A year later, the FDA required Invokana manufacturers to add black box warnings to the drug’s labels, warning patients about an increased risk of leg and foot amputations. A black box warning label is the strongest warning the FDA can place on a drug.

According to the FDA, patients should immediately notify their doctors if they experience:

• New pain or tenderness in legs or feet
• Sores or ulcers in legs or feet
• Infections in legs or feet

The FDA also states that health care professionals should discontinue Invokana treatment in patients if the risk of lower limb amputations occurs.

Final results from two large clinical trials found that leg and foot amputations doubled in patients treated with type 2 diabetes medicine Invokana than in those on an inactive treatment. While the toe and middle of the foot amputations occurred the most, some patients suffered the leg, below and above the knee amputations, or had more than one amputation.

According to the trials, people who had a history of prior amputation, peripheral vascular disease, and neuropathy were at the highest risk of amputation.

One the clinical trials has also found a small increase in diabetic ketoacidosis in patients taking Invokana. In 2015, the FDA strengthened the warnings by including information about potential risks of developing ketoacidosis and urinary tract infections. Find more information about ketoacidosis from Invokana here.

Lawsuits are being filed against Janssen Pharmaceuticals and their parent company Johnson & Johnson, the manufacturers of the diabetes drug Invokana, for failing to warn about several serious and potentially deadly side effects, like amputations. The FDA has issued several recent warnings about side effects of Invokana, and many people are coming forward after developing ketoacidosis and other serious injuries.

By filing an Invokana Lawsuit, you may be able to receive financial compensation for your injuries, lost wages, and other expenses.

If you or a loved one was injured as a result of taking Invokana, we will offer you a free lawsuit evaluation from one of our experienced Invokana Lawyers.

NastLaw is investigating claims of people who took Invokana and suffered an amputation, as well as other severe injuries. Contact us today for more information and to find out if you are eligible for an Invokana Lawsuit.

Many people are filing lawsuits against Johnson & Johnson Pharmaceuticals, one of the world’s largest drug manufacturers, but others are still unaware of the potential health risks Invokana possesses. Amputations, ketoacidosis, heart attack and other dangerous side effects can seriously damage one’s health, and can lead to hospitalization or death. The FDA has issued several recent warnings about side effects of Invokana, and many people are coming forward after suffering health problems.

By filing an Invokana Lawsuit, you may be able to receive financial compensation for your injuries, lost wages, and other expenses. Our lawyers are offering free, no obligation lawsuit evaluations — contact us today to discuss a potential Invokana Lawsuit.